News

Latest

May 14, 2019
House Energy and Commerce Committee leaders today released a discussion draft of bipartisan legislation to address surprise medical bills.
May 14, 2019
Three hundred two members of the House of Representatives yesterday urged House leadership to delay for at least two years the Medicaid disproportionate share hospital cuts scheduled to take effect Oct. 1.
May 14, 2019
Eligible hospitals and critical access hospitals that did not qualify as meaningful users of certified electronic health record technology for the 2019 Medicare Promoting Interoperability Program may apply for a hardship exception to avoid the associated payment penalty.
May 14, 2019
The largest U.S. pharmaceutical and biotech companies spend just 22 cents out of every dollar on research and development, according to an analysis released today by the Campaign for Sustainable Rx Pricing.
May 14, 2019
The Health Resources and Services Administration yesterday awarded 120 organizations, including hospitals, $200,000 each to develop community partnerships and plans to prevent and reduce opioid use disorder in high-risk rural counties.
May 13, 2019
As part of its efforts to promote behavioral health strategies, the AHA today released a TrendWatch report outlining the opportunities, barriers and solutions to increase access to behavioral health care. 
May 13, 2019
The Food and Drug Administration last week alerted health care providers and patients that batteries in certain Medtronic implantable pacemakers and cardiac resynchronization therapy pacemakers may drain more quickly than expected without warning.
May 13, 2019
The AHA and other plaintiffs late Friday asked a federal district judge to set a firm June deadline for the Department of Health and Human Services to propose remedies to the nearly 30 percent cuts to Medicare payments affecting certain hospitals that participate in the 340B Drug Pricing Program.
May 13, 2019
The Food and Drug Administration Friday issued final guidance clarifying how sponsors may show that a proposed biosimilar product is interchangeable with a brand name biological product.
May 13, 2019
Whistleblowers who file a lawsuit within three years of reporting an alleged fraud to a responsible government official may have up to 10 years after the alleged fraud occurred to file a lawsuit.